摘要
前列腺癌发病率、死亡率逐年升高,是肿瘤防治最受关注的恶性肿瘤之一。去势抵抗性前列腺癌(castration-resistant prostate cancer,CRPC)患者的规范化药物治疗是提高患者生存时间、改善生存质量的关键方法。本文将就近年来有关CRPC药物治疗的现状及最新进展进行综述。
The incidence and mortality of prostate cancer have steadily increased.As such,the prevention and treatment of prostate cancer are important.Standardized drug therapy in patients with castration-resistant prostate cancer(CRPC)is crucial for improving survival and quality of life.Here,we review the current situation and latest research progress in drug therapy for CRPC.
作者
管考鹏
Kaopeng Guan(Department of Urology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China)
出处
《中国肿瘤临床》
CAS
CSCD
北大核心
2020年第8期384-387,共4页
Chinese Journal of Clinical Oncology
关键词
去势抵抗性前列腺癌
药物治疗
进展
castration-resistant prostate cancer(CRPC)
drug therapy
progress
